Legend Biotech Corp
corporate_fare Company Profile
Legend Biotech Corp (NASDAQ:LEGN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 35 items for LEGN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for LEGN spans 6-K, 424B5, F-6EF.
Recent high-impact activity:
- Legend Biotech Swings to Q3 Profit: $51.7M Net Income, $359.5M Revenue
- Legend Biotech Posts $359.5M in Q3 Revenue
- Legend Biotech Wins FDA IND Clearance for First Dual-Targeting In Vivo CAR-T (LB2501)
- FDA Clears IND for First Dual-Targeting In Vivo CAR-T Therapy
- Legend Biotech Reports Preliminary Q3 CARVYKTI Sales of ~$710M
Financial Snapshot
Short Interest & Short Volume
6.29 days to coverFINRA reported short interest of 11,899,858 shares in LEGN as of the October 30, 2026 settlement, a 14.4% decrease from the prior period — about 6.3 days to cover at its recent average daily volume. On November 20, 2026, 46.1% of LEGN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for LEGN, detected from its recent SEC filings · based on capital-structure filings through 2026-06-18.
Public Offering Finalized · Significant Capital Raise
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
LEGN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.